Canagyn

Natural health product licensed in Canada

Licence holder

PalCare Enterprises Inc

NPN or DIN-HM

80094736

Status

Active licence

Licence date

4 October 2019

Revision date

22 September 2022

Form

Suppositoire

Route of administration

Vaginale

Application type

Non traditionnelle

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Cétéareth-25, Hydrogenated cocoglycerides, Lactate de sodium, Polyglyceryl-3 Ricinoleate, Acide L-lactique

Recommended doses in Canada

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps reduce the overgrowth of recurrent or resistant vaginal yeast. Helps relieve recurrent vaginal infections such as candidiasis. Helps to reduce the incidence of recurrent Vulvovaginal Candidiasis. Traditionally used in herbal medicine for secretions associated with vaginitis. Helps to treat symptoms of recurrent Yeast Vaginitis and Vulvovaginal Candidias.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80094736

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 22 September 2022 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging